Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3771495010 | Salicylic acid and zinc oxide only product in cutaneous dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3771496011 | Product containing only salicylic acid and zinc oxide in cutaneous dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Salicylic acid and zinc oxide only product in cutaneous dose form | Is a | Salicylic acid- and zinc oxide-containing product in cutaneous dose form | true | Inferred relationship | Some | ||
| Salicylic acid and zinc oxide only product in cutaneous dose form | Count of base of active ingredient | 2 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Salicylic acid and zinc oxide only product in cutaneous dose form | Is a | Salicylic acid and zinc oxide only product | true | Inferred relationship | Some | ||
| Salicylic acid and zinc oxide only product in cutaneous dose form | Has manufactured dose form | Cutaneous dose form | true | Inferred relationship | Some | ||
| Salicylic acid and zinc oxide only product in cutaneous dose form | Has active ingredient | Zinc oxide | true | Inferred relationship | Some | 2 | |
| Salicylic acid and zinc oxide only product in cutaneous dose form | Has active ingredient | Salicylic acid (substance) | true | Inferred relationship | Some | 1 | |
| Salicylic acid and zinc oxide only product in cutaneous dose form | Plays role | Antifungal therapeutic role (role) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely salicylic acid 50 microgram/1 milligram and zinc oxide 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | Is a | True | Salicylic acid and zinc oxide only product in cutaneous dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR